MediciNova Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Revenue	1	1	0	4.04	0	0	Upgrade
Gross Profit	1	1	0	4.04	0	0	Upgrade
Selling, General & Admin	5.11	5.24	5.48	5.72	6.69	7.95	Upgrade
Research & Development	5.96	5.66	9.14	8.54	7.48	6.08	Upgrade
Other Operating Expenses	-0.45	0	0	0	0	0	Upgrade
Operating Expenses	10.63	10.9	14.63	14.25	14.18	14.03	Upgrade
Operating Income	-9.63	-9.9	-14.63	-10.22	-14.18	-14.03	Upgrade
Other Expense / Income	-1.22	-1.33	-0.56	-0.08	-0.32	-1.1	Upgrade
Pretax Income	-8.41	-8.57	-14.07	-10.13	-13.86	-12.93	Upgrade
Income Tax	0	0	0	0	-0	0.01	Upgrade
Net Income	-8.41	-8.57	-14.07	-10.13	-13.85	-12.94	Upgrade
Shares Outstanding (Basic)	49	49	49	49	44	43	Upgrade
Shares Outstanding (Diluted)	49	49	49	49	44	43	Upgrade
Shares Change	-	0.00%	0.92%	9.42%	2.91%	4.95%	Upgrade
EPS (Basic)	-0.17	-0.17	-0.29	-0.21	-0.31	-0.30	Upgrade
EPS (Diluted)	-0.17	-0.17	-0.29	-0.21	-0.31	-0.30	Upgrade
Free Cash Flow	-8.14	-7.45	-12.92	-9.41	-10.86	-9.14	Upgrade
Free Cash Flow Per Share	-0.17	-0.15	-0.26	-0.19	-0.24	-0.21	Upgrade
Gross Margin	100.00%	100.00%	-	100.00%	-	-	Upgrade
Operating Margin	-962.57%	-990.03%	-	-253.02%	-	-	Upgrade
Profit Margin	-840.85%	-857.15%	-	-251.00%	-	-	Upgrade
Free Cash Flow Margin	-814.32%	-745.23%	-	-233.07%	-	-	Upgrade
EBITDA	-8.19	-8.35	-13.85	-9.89	-13.62	-12.91	Upgrade
EBITDA Margin	-818.96%	-835.37%	-	-244.93%	-	-	Upgrade
Depreciation & Amortization	0.22	0.21	0.21	0.24	0.23	0.02	Upgrade
EBIT	-8.41	-8.57	-14.07	-10.13	-13.86	-12.93	Upgrade
EBIT Margin	-840.55%	-856.85%	-	-250.94%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).